Life science assets have made the list of commercial real estate darlings, along with industrial and multifamily. That means a slew of new capital is entering the market—but Bill Kane, president of East Coast and UK markets at BioMed Realty says that the highly specialized sector isn't for everyone.

"The life science sector has been resilient, and we remain strong believers in long-term market fundamentals. While we're seeing an uptick in companies that want to capitalize on the life science boom, it takes a truly specialized team to develop and manage these complex properties and portfolios and establish trust with the occupants," Kane tells GlobeSt.com.

BioMed has been active in the life science market since long before it became a popular asset. "We have decades of expertise and experience from developing ground up lab space and office-to-lab conversions, which is an important factor when clients look for a real estate partner in the core markets," says Kane.